Can-Fite publishes study results on canine osteoarthritis drug

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/30/2026

1. META
2. MSFT
3. FTNT
4. QCOM
5. ARM
6. SBUX
7. CVNA
8. TENB
9. SPY
10. BSX

Go back to Can-Fite publishes study results on canine osteoarthritis drug
CAN-FITE BIOPHARMA LTD. (NYSE: CANF) Delayed: 3.28 +0.08 (2.50%)
Previous Close $3.20    52 Week High $3.89 
Open $3.22    52 Week Low $1.85 
Day High $3.32    P/E N/A 
Day Low $3.18    EPS $0.00 
Volume 48,919       

(NASDAQ: CFBI) Delayed: 10.08 --0 (-0%)
Previous Close $10.08    52 Week High $ 
Open $41.64    52 Week Low $ 
Day High $10.08    P/E N/A 
Day Low $10.08    EPS $ 
Volume 206